TKT and glioblastoma: (75) investigated the safety and feasibility of treating patients with primary and secondary polymorphic GBM with lentiviral transduced autologous bone marrow MSC containing herpes simplex virus thymidine kinase (HSV-TK) in combination with intravenous ganciclovir.